Fact CheckerSign in

NCT07411508Active, not recruiting

The Effects of Face-to-face and Tele-nursing Education on Fatigue, Pain, Sleep, and Urinary Tract Infections in Patients With Multiple Sclerosis.

Investigation of the Effects of Education Provided Through Face-to-face and Tele-nursing Based on Pender's Health Promotion Model on Fatigue, Pain, Sleep, and Urinary Tract Infections ın Patients With Multiple Sclerosis: a Randomized Controlled Trial.

Source: ClinicalTrials.gov · Last updated 19 Feb 2026

Brief summary (registry, in English)

The aim of this study is to evaluate the effects of face-to-face and distance nursing education, based on Pender's Health Promotion Model, on fatigue, pain, sleep, and urinary tract infections in MS patients who applied to the Multiple Sclerosis Outpatient Clinics of Sakarya Training and Research Hospital. With this research, the researcher aims to reduce MS symptoms and severity, prevent secondary problems, and improve quality of life.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
96 (actual)
First submitted
8 Dec 2025
Start date
1 Apr 2024
Primary completion date
1 Apr 2026
Lead sponsor
ugurlu
NCT number
NCT07411508

What you commit to

  • Study type: Interventional
  • Participants enrolled: 96
  • From 1 Apr 2024 to the primary completion date, 1 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have used other complementary therapies such as acupuncture, yoga, meditation, etc. during the study period,

Other illness

  • Have a hearing or visual impairment,
  • Have developed serious physical or mental illnesses during the study period,
  • Have been in an attack phase of the disease or have conditions requiring hospitalization during the intervention will not be included in the study.

Other

  • Patients who are unwilling to participate in the study for any reason,
  • Have a communication disability,
  • Have failed to attend three consecutive training sessions unless medically indicated,
  • Have not completed 70% of the training program (or 17 of 24 sessions) (Alonso Martínez et al., 2023),
  • Have been found to be unsuitable for participation in the study (as assessed by a psychologist or psychiatrist),

Who the study is looking for

  • Patients who are willing to participate in the study,
  • Age between 18-55,
  • Literate,
  • Diagnosed at least 1 year ago,
  • Diagnosed with Relapsing-Remitting MS (the most common type, RRMS, which progresses with attacks and remissions),
  • A specialist (psychologist or psychiatrist) has determined that their cognitive level is suitable for participation in the study,
  • Scoring their pain 4 points or higher on the Visual Analog Scale (VAS),
  • Scoring 4 or higher on the Fatigue Severity Scale (FSS),
  • Scoring 10 or higher on the Epworth Sleepiness Scale (ESS),
  • Having not used any other complementary and alternative treatments in the last 6 months,
  • Patients who own or have a family member who owns a smartphone, tablet, or computer will be included (Eren, 2018).

Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sakarya University Institute of Health Sciences
Coordinator of this site? Confirm its status
SakaryaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.